Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-02-03 @ 6:34 AM
Study NCT ID:
NCT00748566
Status:
TERMINATED
Last Update Posted:
2021-03-03
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Schizophrenia and Disorders With Psychotic Features | View |